Ixazomib price list in 2024

Ixazomib, as a new innovative targeted drug developed by Takeda Pharmaceutical Co., Ltd., has attracted much attention since its launch. This drug is usually used in combination with lenalidomide and dexamethasone to treat multiple myeloma in people who have received at least one prior therapy. In China, this drug has been successfully launched and included in medical insurance, bringing hope to patients.

In the domestic market, because ixazomib is an imported original drug, its price is relatively high, about RMB 10,000 to 20,000 per box, which is unaffordable for ordinary patients. Fortunately, medical insurance reimbursement policies can alleviate some of the financial pressure, which reduces the financial burden on patients to a certain extent. But even so, patients still have to bear a considerable portion of the cost. In addition, medical insurance reimbursement usually has certain conditions, and patients who do not meet the requirements need to purchase it at their own expense. For specific drug pricing and medical insurance policies, patients should consult the local medical insurance bureau and hospital pharmacy.

On the other hand, overseas markets offer more economical options. In the Laotian market, generic drugs produced by Lucius Pharmaceuticals have attracted much attention. While ensuring quality, this generic drug is more affordable. Each box (4mg*3 pills) only costs about 900 yuan, which is far lower than the price of domestic original drugs.

In general,The price of ixazomib in 2024 will vary depending on the market and policies. In the domestic market, although the price is higher, the medical insurance policy provides certain financial support for patients; while in the overseas market, especially the generic version of Laos, it provides patients with a more economical choice. When purchasing, patients should choose the version of the drug that best suits them based on their own circumstances and economic conditions. At the same time, patients are advised to learn more about the source and quality of drugs before purchasing to ensure the safety and effectiveness of the drugs.